Clinical Trial

Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy

Study acronym: HiPPo
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective study of hilotherapy of hands and feet as prevention of chemotherapy-induced peripheral polyneuropathy induced by Taxan-based chemotherapy regimen that are used in the therapy of breast cancer and genital malignoma of the women.
Trial Details
NCT Number NCT06627348
Lead Sponsor University of Ulm
Collaborators: Hilotherm
Conditions Equipment and Supplies
Enrollment 150 participants
Start Date 2024-04-17
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-04